The National Health Insurance Administration (NHIA) said it plans to expand the coverage eligibility for receiving a third-generation targeted drug for lung cancer patients with the epidermal growth factor receptor (EGFR) starting next month.
The eligibility would be expanded to include people with stage 3b EGFR-mutated lung cancer, which is expected to benefit about 4,000 people, allowing them to save about NT$1.15 million (US$36,005) per year in medical expenses.
The expanded eligibility is expected to cost the NHI program between NT$4.1 billion and NT$5 billion per year, and with the annual expense of about NT$3.3 billion on eligible patients, the targeted drug would be the most expensive single type of drug in NHI history.
Photo: Chiu Chih-jou, Taipei Times
Lung adenocarcinoma is the most common type of lung cancer in Taiwan and KRAS mutations occur in about 20 to 40 percent of lung adenocarcinomas in Western populations, NHIA Director-General Shih Chung-liang (石崇良) said.
However, in Taiwan, KRAS mutations only occur in about 8 to 10 percent of patients with lung adenocarcinomas, while EGFR mutations occur in about 55 to 60 percent of patients with lung adenocarcinomas, he said.
The NHI program since April 2020 has conditionally covered a third-generation targeted drug called Tagrisso (osimertinib) for the treatment of EGFR-mutated lung cancer, but the eligibility was reduced in April 2022, which had caused an uproar among patients and medical professionals.
Studies published in international journals have suggested that compared with the first-generation targeted drug, the third-generation drug can reduce the risk of mortality by 20 percent.
With many calls for the NHI program to expand eligibility, Shih said the administration plans to expand the eligibility of Tagrisso from its current eligibility of stage 4 (metastasized) lung cancer to include stage 3b EGFR-mutated lung cancer with local invasiveness or metastases.
The Pharmaceutical Benefit and Reimbursement Scheme Joint Committee has approved the expanded eligibility, and it is scheduled to take effect on Oct. 1 at the earliest, he said.
About 3,400 people are treated with Tagrisso each year, which is an NHI expenditure of about NT$3.3 billion per year, NHIA statistics showed. After the eligibility expansion, it would increase the expenditure to more than NT$7 billion.
The total expenditure for NHI-covered medical treatment last year was more than NT$24.3 billion, the highest among all cancer types, and drug fees accounted for NT$12.2 billion, with a five-year average growth rate of 12.7 percent.
Regarding people with lung cancer without gene mutations that cannot receive the targeted drug, Shih said specialists have suggested including immunotherapy drugs for treating metastasized small cell lung cancer in NHI coverage, so there might be good news after the agency negotiates with drug companies.
An estimated 272 to 359 patients each year are expected to benefit from it, allowing them to save about NT$1.45 million per person per year, he added.
WANG RELEASED: A police investigation showed that an organized crime group allegedly taught their clients how to pretend to be sick during medical exams Actor Darren Wang (王大陸) and 11 others were released on bail yesterday, after being questioned for allegedly dodging compulsory military service or forging documents to help others avoid serving. Wang, 33, was catapulted into stardom for his role in the coming-of-age film Our Times (我的少女時代). Lately, he has been focusing on developing his entertainment career in China. The New Taipei District Prosecutors’ Office last month began investigating an organized crime group that is allegedly helping men dodge compulsory military service using falsified documents. Police in New Taipei City Yonghe Precinct at the end of last month arrested the main suspect,
A cat named Mikan (蜜柑) has brought in revenue of more than NT$10 million (US$305,390) for the Kaohsiung MRT last year. Mikan, born on April 4, 2020, was a stray cat before being adopted by personnel of Kaohsiung MRT’s Ciaotou Sugar Refinery Station. Mikan was named after a Japanese term for mandarin orange due to his color and because he looks like an orange when curled up. He was named “station master” of Ciaotou Sugar Refinery Station in September 2020, and has since become famous. With Kaohsiung MRT’s branding, along with the release of a set of cultural and creative products, station master Mikan
RISING TOURISM: A survey showed that tourist visits increased by 35 percent last year, while newly created attractions contributed almost half of the growth Changhua County’s Lukang Old Street (鹿港老街) and its surrounding historical area clinched first place among Taiwan’s most successful tourist attractions last year, while no location in eastern Taiwan achieved a spot in the top 20 list, the Tourism Administration said. The listing was created by the Tourism Administration’s Forward-looking Tourism Policy Research office. Last year, the Lukang Old Street and its surrounding area had 17.3 million visitors, more than the 16 million visitors for the Wenhua Road Night Market (文化路夜市) in Chiayi City and 14.5 million visitors at Tainan’s Anping (安平) historical area, it said. The Taipei 101 skyscraper and its environs —
Taiwan on Friday said a New Zealand hamburger restaurant has apologized for a racist remark to a Taiwanese customer after reports that it had first apologized to China sparked outrage in Taiwan. An image posted on Threads by a Taiwanese who ate at Fergburger in Queenstown showed that their receipt dated Sunday last week included the words “Ching Chang,” a racial slur. The Chinese Consulate-General in Christchurch in a statement on Thursday said it had received and accepted an apology from the restaurant over the incident. The comment triggered an online furor among Taiwanese who saw it as an insult to the
RSS